|
Market Closed -
Boerse Muenchen
16:43:02 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 0.3620 EUR | 0.00% |
|
-5.36% | +21.68% |
| 08-10 | Nicox Sa and Ocumension Therapeutics Submit Ncx 470 New Drug Application in China | CI |
| 08-10 | Nicox Partner Files China Drug Application for NCX 470 Eye Drop | MT |
Company Valuation: Nicox SA
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 109.8 | 55.83 | 22.05 | 19.32 | 24.12 | 33.71 | - |
| Change | - | -49.18% | -60.51% | -12.36% | 24.81% | 39.78% | - |
| Enterprise Value (EV) | 89.38 | 53.61 | 31.68 | 19.32 | 24.12 | 33.71 | 33.71 |
| Change | - | -40.02% | -40.9% | -39.01% | 24.81% | 39.78% | 0% |
| P/E | -2.18x | -1.78x | -1.05x | -0.88x | -9.93x | -5.46x | 38.3x |
| PBR | 1.45x | 1.04x | - | - | - | - | - |
| PEG | - | 0x | 0x | 0x | 0.1x | -0x | -0x |
| Capitalization / Revenue | 15.2x | 17.1x | 5.25x | 2.46x | 1.44x | 11.2x | 3.37x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 11.2x | 3.37x |
| EV / EBITDA | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | 0x | -5.62x | 33.7x |
| EV / FCF | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - |
| EPS 2 | -1.17 | -0.63 | -0.42 | -0.32 | -0.03 | -0.07 | 0.01 |
| Distribution rate | - | - | - | - | - | - | - |
| Net sales 1 | 7.233 | 3.271 | 4.2 | 7.859 | 16.77 | 3 | 10 |
| EBITDA | -16.61 | -22.86 | -17.04 | - | - | - | - |
| EBIT 1 | -46.01 | -33.96 | -17.06 | -9.854 | 4.626 | -6 | 1 |
| Net income 1 | -43.76 | -27.76 | -20.88 | -22.39 | -2.413 | -6 | 1 |
| Net Debt | -20.46 | -2.216 | 9.636 | - | - | - | - |
| Reference price 2 | 2.5550 | 1.1200 | 0.4420 | 0.2810 | 0.2980 | 0.3825 | 0.3825 |
| Nbr of stocks (in thousands) | 42,991 | 49,845 | 49,882 | 68,764 | 80,926 | 88,131 | - |
| Announcement Date | 4/28/22 | 3/20/23 | 4/22/24 | 4/29/25 | 4/30/26 | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 111.1x | 6.17x | 26.18x | 2.24% | 376B | |
| 23.21x | 3.15x | 11.05x | 1.71% | 70.02B | |
| 15.01x | 7.35x | 11.26x | - | 12.28B | |
| 16.64x | 2.12x | 7.04x | 2.7% | 8.49B | |
| 19.68x | 6.2x | 16.5x | -.--% | 4.73B | |
| 41.32x | 2.59x | 29.55x | 0.69% | 4.43B | |
| 27.37x | 5.25x | 15.02x | - | 3.2B | |
| -229.25x | - | - | -.--% | 2.67B | |
| Average | 3.14x | 4.69x | 16.66x | 1.22% | 60.27B | |
| Weighted average by Cap. | 90.26x | 5.65x | 23.11x | 2.12% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALCOX Stock
- NXOA Stock
- Valuation Nicox SA
Select your edition
All financial news and data tailored to specific country editions
